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There is evidence that the ``acid mantle'' of the
stratum corneum is important for both permeability
barrier formation and cutaneous antimicrobial
defense. The origin of the acidic pH of the stratum
corneum remains conjectural, however. Both passive
(e.g., eccrine/sebaceous secretions, proteolytic) and
active (e.g., proton pumps) mechanisms have been
proposed. We assessed here whether the free fatty
acid pool, which is derived from phospholipase-
mediated hydrolysis of phospholipids during corni®-
cation, contributes to stratum corneum acidi®cation
and function. Topical applications of two chemically
unrelated secretory phospholipase sPLA2 inhibitors,
bromphenacylbromide and 1-hexadecyl-3-tri¯uor-
oethylglycero-sn-2-phosphomethanol, for 3 d pro-
duced an increase in the pH of murine skin surface
that was paralleled not only by a permeability barrier
abnormality but also altered stratum corneum integ-
rity (number of strippings required to break the
barrier) and decreased stratum corneum cohesion
(protein weight removed per stripping). Not only
stratum corneum pH but also all of the functional
abnormalities normalized when either palmitic, stea-
ric, or linoleic acids were coapplied with the inhibi-
tors. Moreover, exposure of intact murine stratum
corneum to a neutral pH for as little as 3 h produced
comparable abnormalities in stratum corneum integ-
rity and cohesion, and further ampli®ed the inhibi-
tor-induced functional alterations. Furthermore,
short-term applications of an acidic pH buffer to
inhibitor-treated skin also reversed the abnormalities
in stratum corneum integrity and cohesion, despite
the ongoing decrease in free fatty acid levels. Finally,
the secretory-phospholipase-inhibitor-induced alter-
ations in integrity/cohesion were in accordance with
premature dissolution of desmosomes, demonstrated
both by electron microscopy and by reduced desmo-
glein 1 levels in the stratum corneum (shown by
immuno¯uorescence staining and vizualized by
confocal microscopy). Together, these results demon-
strate: (i) the importance of phospholipid-to-free-
fatty-acid processing for normal stratum corneum
acidi®cation; and (ii) the potentially important role
of this pathway not only for barrier homeostasis but
also for the dual functions of stratum corneum integ-
rity and cohesion. Key words: acidi®cation/epidermis/
fatty acids/free fatty acids/pH/phospholipases/phospho-
lipids/secretory phospholipases/stratum corneum. J Invest
Dermatol 117:44±51, 2001
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lthough ®rst recognized several decades ago (Schade
and Marchionini, 1928; Blank, 1939; Draize, 1942;
Beare et al, 1958; Baden and Pathak, 1967; Dikstein
and Zlotogorski, 1994; Ohman and Vahlquist, 1994,
1998), the origin and function of the ``acid mantle''
of the stratum corneum (SC) remains conjectural. One function of
SC acidi®cation appears to be antimicrobial, because an acidic pH
inhibits colonization by pathogenic bacteria such as Staphylococcus
aureus (Aly et al, 1975; Puhvel et al, 1975). Conversely, alkaliniza-
tion of the SC, as occurs in the urea-soaked skin of diaper
dermatitis, is an important antecedent of bacterial and yeast
infections (Leyden and Kligman, 1978; Brook, 1992). A second,
key function of an acidic SC relates to the activation of lipid
hydrolases, which process secreted polar lipids, a sequence required
for normal barrier function (Elias and Menon, 1991). Barrier
recovery after acute injuries is impeded at a neutral versus acidic pH
(Mauro et al, 1998), apparently because one or more secreted
hydrolases, e.g., b-glucocerebrosidase (Holleran et al, 1992; Takagi
et al, 1999), display an acidic pH optimum. b-Glucocerebrosidase,
with acid sphingomyelinase, represent two such critical processing
enzymes, with acidic pH optimum, that generate a family of
ceramides required for epidermal permeability barrier homeostasis
(Holleran et al, 1993; Jensen et al, 1999; Schmuth et al, 2000).
Both active (energy-requiring) and passive (nonenergy-requir-
ing) mechanisms have been proposed for the origin of the acid
mantle of the SC. Passive exogenous mechanisms include: (i) free
fatty acids (FFA), generated by lipases of bacterial and/or
pilosebaceous origin (Puhvel et al, 1975); or (ii) eccrine-gland-
derived products such as lactic acid (Ament et al, 1997). Passive
processes, mediated by hydrolytic enzymes, include bulk proteo-
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lysis that accompanies catabolic processes late in terminal differen-
tiation (Freinkel and Traczyk, 1983). Another passive mechanism,
i.e., generation of cis-urocanic acid from histidine, was proposed
recently to be the major, if not the sole, source of the acidi®cation
of the SC aqueous compartment (Krien and Kermici, 2000). This
mechanism, however, may not be relevant either for hydrolytic
processes that occur deep in the SC, or for those within the
hydrophobic, extracellular compartments of the SC. It is in these
domains that the processing events leading to the dual SC functions
of barrier formation and desquamation largely occur (Elias and
Menon, 1991). Moreover, to what extent this mechanism is
operative under conditions of high humidity, when less histidine
would be available as a precursor for cis-urocanic acid generation
(Scott et al, 1982; Scott and Harding, 1986), is unknown.
A third, passive, enzymatic mechanism could come from the
generation of proton-donating FFA, resulting from the bulk
hydrolysis of epidermal phospholipids (PL) or other complex lipids
late in terminal differentiation. PL disappear during corni®cation
(Elias et al, 1988), and a family of nonessential FFA, required for
normal barrier homeostasis, results from the bulk hydrolysis
(processing) of PL within the SC interstices (Mao-Qiang et al,
1995). Although the responsible phospholipase(s) has (have) not
been identi®ed (Long and Yardley, 1972; Freinkel and Traczyk,
1980; Forster et al, 1983; 1985; Bergers et al, 1988; Andersen et al,
1994; Li-Stiles et al, 1998; Mazereeuw-Hautier et al, 2000),
applications of inhibitors of the 14 kDa family of secretory
phospholipases (sPLA2) block the processing of PL, while inducing
abnormalities in permeability barrier homeostasis (Mao-Qiang et al,
1995; 1996). We assessed here whether applications of these sPLA2
inhibitors also induce abnormalities in SC acidity, as well as the
potential functional consequences of such alterations. Our studies
demonstrate that PL-to-FFA processing is an important source of
SC acidi®cation. Furthermore, we show that inhibition of FFA
generation from PL results not only in altered barrier function, but
also in abnormalities in SC integrity and cohesion.
MATERIALS AND METHODS
Materials Male hairless mice (Skh1/Hr), 8±12 wk old, were purchased
form Charles River Laboratories (Wilmington, MA) and fed Purina
mouse diet and water ad libitum. Propylene glycol, ethanol, NaOH, and
HCl were from Fisher Scienti®c (Fairlane, NJ), whereas palmitic acid
(PA), stearic acid, linoleic acid, HEPES buffer, and bromophenacyl
bromide (BPB) were from Sigma Chemical (St. Louis, MO). 1-
hexadecyl-3-tri¯uoroethylglycero-sn-2-phosphomethanol (MJ33) was
synthesized as described previously (Jain et al, 1991). The stripping for
the protein assay was performed with 22 mm D-Squame 100 tapes
purchased from CuDerm (Dallas, TX). Bradford protein assay kits (Bio-
Rad Protein Assay Dye), as well as lyophilized, bovine plasma gamma
globulin were purchased from Bio-Rad (Hercules, CA).
Experimental procedures, pH determinations, and transepidermal
water loss (TEWL) measurement Normal hairless mice were treated
topically twice daily for 3 d with BPB (4 mg per ml) or MJ33 (4 mg per
ml), both in propylene glycol:ethanol (7:3 vol/vol) vehicle, or the
vehicle alone on an area of 5±6 cm2 on the backs and ¯anks, as
described previously (Mao-Qiang et al, 1996). The doses that we
employed were shown previously to be nontoxic to murine skin (Mao-
Qiang et al, 1995; 1996), and to inhibit secretory PLA2 activity
selectively in different tissues and cell types (Jain et al, 1991; Gelb et al,
1994). For the override experiments, animals received coapplications of
either palmitic acid, stearic acid, or linoleic acid (10 mg per ml), at the
same time that these sites were treated with the inhibitor in one
solution. The acidi®cation experiments were performed with 10 mM
HEPES buffer, adjusted to either pH 5.5 or pH 7.4, as follows. One
¯ank of the anesthetized mice was immersed on a mesh netting, as
described previously (Lee et al, 1992). The mice were anesthetized with
chloral hydrate (Morton Grove Pharmaceuticals, Morton Grove, IL).
After 3 h of immersion at 37°C, the mice were removed, and the
remaining buffer was gently blotted off. After 15 min, barrier function
was determined by measurement of TEWL with an electrolytic water
analyzer (MEECOâ; Warrington, PA). Surface pH was measured with a
¯at, glass surface electrode from Mettler-Toledo (Giessen, Germany),
attached to a pH meter (Skin pH Meter PH 900; Courage & Khazaka,
Cologne, Germany).
Immuno¯uorescence staining Hairless mouse skin was excised with
a 6 mm punch biopsy, and the subcutaneous fat was removed. Tissue
sections were incubated for 1 h in blocking buffer (1% bovine serum
albumin, 0.1% cold water ®sh gelatin in phosphate-buffered saline, PBS)
and were then incubated for 1 h further at room temperature with 1:500
dilution of polyclonal rabbit antimouse desmoglein 1 (DSG 1) antibody
(gift of Dr. John Stanley, University of Pennsylvania) diluted in blocking
buffer. The tissue was then washed with blocking buffer and incubated
for 1 h at room temperature with ¯uorescein-labeled, isothiocyanate-
conjugated, goat antirabbit IgG antibody (DAKO, Carpinteria, CA),
diluted in blocking buffer. Either preincubation of DSG 1 antibody with
DSG-1-recombinant protein (gift of Dr. Masayuki Amagai, Keio
University, Tokyo, Japan), or omission of the DSG 1 primary antibody
eliminated speci®c staining. Tissue sections were then washed with PBS
and coverslipped before visualization under a confocal microscope (Leica
TCS SP, Heidelberg, Germany) using ¯uorescein isothiocyanate at an
excitation wavelength of 494 nm and an emission wavelength of
518 nm.
Protein assay on sequential tape strips The protein assay utilized the
Bradford dye-binding procedure for quanti®cation of total protein
(Bradford, 1976). HEPES buffer and propylene glycol:ethanol, the two
vehicles used in this study, are known to be compatible with this assay
(Protein assay, Product Information, Bio-Rad, Hercules, CA). Before
stripping the SC, the skin surface was cleaned with a single ethanol
wipe. D-Squame tapes were then placed sequentially to the test areas for
about 3 s each, removed with forceps, and stored in glass scintillation
vials at 5°C.
The amount of protein removed per D-Squame was measured by a
modi®cation of the method of Dreher et al (1998). The microassay
system was shown to be linear in the range 1±10 mg per ml, using
human SC removed from a heel callosity. The calculated slope Rf 6 SD
is 0.0297 6 0.00062; Spearman coef®cient 0.999; p < 0.0001.
The protein content per stripping was determined with the Bio-Rad
Protein Assay Kit. Lyophilized, bovine gamma globulin was used as the
standard in all assays, because it correlated best with human SC. Each
tape was incubated with 1 ml of 1 M NaOH for 1 h at 37°C in an
incubator shaker at 80 rpm, and neutralized thereafter with 1 ml of 1 M
HCl in the scintillation vials. Subsequently 0.2 ml of this solution was
incubated in 0.6 ml distilled water plus 0.2 ml of the Bio-Rad protein
dye for 5 min in borosilicate tubes. After incubations, the reagents were
transferred to polysterene cuvettes, and absorption was measured with a
Genesys 5 spectrophotometer (Spectronic, Rochester, NY) at 595 nm.
An empty D-Squame tape, as well as distilled water incubated with the
Bio-Rad dye, served as negative controls. The amount of calculated
protein was then normalized to skin surface area (mg per cm2). The
amount of removed protein per D-Squame strip agreed with previous
reports in untreated skin of hairless mice (i.e., range 2.5±4 mg per strip)
(Weber et al, 1999).
Statistical analyses Statistical analyses were performed using Prism 2
(GraphPad Software, San Diego, CA). Normal distribution was tested
before calculating the comparison. In the three group comparisons we
calculated an ANOVA followed by a posthoc test (Bonferroni). Two
groups were compaired with an unpaired t test.
RESULTS
Inhibition of PL-to-FFA processing increases the pH of
the SC, while altering barrier homeostasis and SC
integrity The surface pH of hairless mouse skin increased
signi®cantly after 1 d of BPB treatment, and continued to
increase up to 3 d in comparison to vehicle-treated sites (Fig 1A;
p < 0.01). As previously reported (Mao-Qiang et al, 1995), daily
topical applications of the group-1-speci®c sPLA2 inhibitor BPB
produce a concurrent, progressive abnormality in barrier function
of normal skin, which becomes evident by day 2 (Fig 1B). The
integrity of the SC, quantitated as the number of tape strippings
required to produce elevated TEWL levels, was also markedly
abnormal after 3 d of BPB treatment. As seen in Fig 1(C), a
signi®cant abnormality was already present at the ®rst stripping, and
SC integrity continued to deteriorate thereafter. These changes in
integrity were paralleled by an increase in the amount of protein
removed per D-Squame stripping (a measure of SC cohesion),
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which again was signi®cant by the ®rst strip, and continued to
diverge from vehicle-treated sites with further stripping (Fig 1D).
These results show that repeated applications of the sPLA2 inhibitor
BPB result in an increased skin surface pH, a change that is
accompanied not only by altered barrier function, but also by
altered SC integrity and cohesion in comparison to the vehicle-
treated control group.
Because BPB is an alkylating agent, which could nonspeci®cally
affect other cellular processes, we performed additional studies with
a chemically unrelated, competitive inhibitor of sPLA2, MJ33,
which is a highly speci®c, competitive inhibitor of group 1 sPLA2.
MJ33 treatment also produced a modest increase in SC surface pH
versus vehicle (5.87 6 0.06 vs 5.60 6 0.05; p = 0.0023). More-
over, as seen previously (Mao-Qiang et al, 1995; 1996), repeated
applications of MJ33 produced a progressive barrier abnormality,
with a 2±3-fold increase in TEWL levels by day 3 (5.19 6 0.81 vs
2.97 6 0.16; p < 0.001, for MJ33 versus vehicle-treated animals).
As with BPB treatments, 3 d of MJ33 applications also progressively
altered SC integrity (Fig 2A), re¯ected by a parallel change in SC
cohesion (Fig 2B). These results show that a second, chemically
unrelated, sPLA2 inhibitor produces comparable changes in skin
surface pH, in parallel with altered SC barrier function, integrity,
and cohesion.
The acidi®cation and cohesion abnormalities are due to
reduced generation of FFA Prior studies have shown that the
barrier abnormality induced by both of the topical sPLA2 inhibitors
can be overridden by coapplications of certain end-products of PL
hydrolysis, i.e., nonessential FFA (Mao-Qiang et al, 1995; 1996).
We con®rmed here, again, that coapplications of either PA (C16:0)
or stearic acid (18:0), with either BPB or MJ33, prevented
emergence of the barrier abnormality (data not shown).
Coapplications of PA, stearic acid, and to a lesser extent linoleic
acid prevented the BPB-induced increase in the pH of the SC (PA,
5.40 6 0.14 vs 5.92 6 0.05; stearic acid, 5.73 6 0.09 vs 6.17 6
0.08; linoleic acid, 5.77 6 0.10 vs 6.28 6 0.10). Furthermore,
coapplications of either stearic acid, PA, and to a lesser extent
linoleic acid also prevented emergence of the sPLA2-inhibitor-
induced abnormalities in SC integrity and cohesion (Fig 3A±D;
linoleic acid data not shown). Likewise, coapplications of PA with
MJ33 prevented emergence of the MJ33-induced abnormality in
SC integrity (Fig 2A, B). These results show that the sPLA2-
inhibitor-induced abnormalities in integrity and cohesion are
linked to increased pH, resulting from decreased generation of
FFA, the end-products of PL hydrolysis by sPLA2.
Figure 1. Alteration of stratum corneum pH
with an sPLA2 inhibitor correlates with
altered barrier function, integrity, and
cohesion. (A) Three days of topical BPB to
intact skin results in a signi®cant increase in SC
surface pH. (B) Barrier function, assessed as
TEWL, increases with 2 d of BPB applications.
(C) SC integrity, assessed as number of tape
strippings in relation to barrier function (TEWL),
declines signi®cantly (data shown are for 3 d of
BPB). (D) SC cohesion, assessed as protein
removed per D-Squame strip, also declines
signi®cantly (data shown are for 3 d of BPB).
Figure 2. A chemically unrelated sPLA2 inhibitor produces
similar changes in SC integrity and cohesion. (A) Three days of
topical MJ33 to intact skin results in a signi®cant increase in TEWL, but
coapplications of FFA (PA) could override this effect; indicated p-values
were determined by ANOVA; the posthoc (Bonferroni) test revealed p
< 0.05 for MJ33 versus vehicle at all data points, and p < 0.01 MJ33
versus MJ33/PA at all data points except at zero D-Squame strippings
(which was not signi®cant). (B) Integrity and cohesion of SC after 3 d of
MJ33 applications to intact skin were signi®cantly reduced; p-values
determined by t test.
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Exposure of normal skin to a neutral pH also produces
abnormalities in pH, barrier function, and integrity/
cohesion To ascertain more directly whether the sPLA2-
inhibitor-induced functional alterations could be due to the
associated pH changes, we next assessed SC integrity after short-
term exposure of normal skin to a neutral versus acidic pH. After
3 h of exposure to a neutral pH buffer (HEPES), the surface pH of
the SC rose from 5.86 6 0.21 to 6.41 6 0.20 (Fig 4A,
p = 0.0257). Whereas exposure to both buffers increased basal
TEWL levels, a slightly greater increase in TEWL occurred
following exposure to the neutral pH buffer for 3 h (all changes
within normal range; data not shown). Even with such short-term
exposures, SC integrity and cohesion declined signi®cantly after 3 h
of treatment with the neutral pH buffer (Fig 4B, C). These studies
show that short-term exposure to a neutral pH buffer alone begin
to produce functional abnormalities that mimic those induced by
the sPLA2 inhibitors.
Exposure to a neutral pH buffer ampli®es the sPLA2-
inhibitor-induced alterations in SC integrity As a further test
of the importance of PL-derived FFA for SC functions, we next
assessed whether exposure of BPB-treated skin to a neutral or acidic
buffer could amplify or override the functional abnormalities
produced by the inhibitor. Exposure of skin sites to BPB for 3 d
provoked an increase in SC pH, which was ampli®ed further by
exposure of the BPB-treated sites to a neutral pH buffer for 3 h.
Exposure to an acidic buffer lowered the surface pH from
5.95 6 0.05 to 5.72 6 0.06 (Fig 5A). In parallel with the
increase in pH, exposure to the neutral pH buffer also
accentuated the BPB-induced abnormality in SC integrity. In
contrast, integrity remained unchanged in BPB-treated sites
exposed to an acidic pH buffer (Fig 5B). These studies
demonstrate further that the abnormalities in SC integrity/
cohesion induced by sPLA2 blockage can be attributed largely to
the acidi®cation abnormality produced by inhibitor treatment.
Premature desmosomal dissolution accounts for the
abnormality in SC integrity/cohesion We next assessed the
basis for the abnormalities in SC integrity and cohesion that result
from application of sPLA2 inhibitors to murine skin. Both
inhibitors provoked a dramatic decrease in the density of
desmosomes in the lower SC and at the stratum granulosum
(SG)±SC interface (Figs 6, 7). Moreover, coapplication of free
fatty acids with the inhibitors reversed the decrease in desmosome
density in the lower SC (Figs 6, 7). Figure 8 shows the reduction
of corneodesmosomes after 3 d of MJ33 treatment, an effect that
could be prevented by coapplication of FFA (PA). BPB treatment
resulted in a comparable reduction of corneodesmosomes (data not
shown). A similar reduction in desmosomes was also shown by
immunohistochemical assessment of DSG-1-positive structures in
the lower SC of BPB versus vehicle-treated SC. On laser confocal
microscopy, the density of DSG-1-positive clusters, which are
presumed to correspond to intact desmosomes, declined
dramatically in BPB-treated SC, whereas DSG-1-positive staining
in vehicle-treated SC was comparable to control (Fig 6). These
results show that the inhibitor-induced decline in SC integrity and
cohesion can be attributed to a premature dissolution of
desmosomes in the lower SC.
DISCUSSION
The acidic pH of the SC could be derived from one or more of
several potential sources (Ohman and Vahlquist, 1998). Until
recently, extrinsic sources were most commonly invoked, e.g.,
secreted eccrine/sebaceous gland products or metabolic byproducts
of resident, cutaneous micro¯ora (Aly et al, 1975; Puhvel et al,
1975). Among potential intrinsic (endogenous) sources, both
passive (catabolic enzymes) and active (proton pumps or exchan-
gers) sources have been postulated. Recently, Krien and Kermici
(2000) proposed that cis-urocanic acid generation, the end-product
of the ®laggrin-to-histidine-to-urocanic acid proteolytic pathway,
could alone explain the acidic pH of the SC. Their assay method,
however, employed an externally applied aqueous receptor, which
probably samples neither the lower SC nor hydrophobic micro-
domains within the SC interstices. It should also be noted that
®laggrin hydrolysis is regulated by changes in external humidity
(Scott et al, 1982; 1986), which, in turn, could in¯uence the
amount of histidine that would be available for cis-urocanic acid
generation. Accordingly, we showed here that an alternative
enzymatic mechanism, i.e., generation of FFA from sPLA2-
mediated catabolism of PL, regulates SC acidi®cation. Topical
applications of two chemically unrelated sPLA2 inhibitors increased
SC pH. As the inhibitor-induced increases, however, did not
achieve a neutral pH, it is likely either that sPLA2 blockade is
incomplete or that other acidi®cation mechanisms compensate, in
part, for sPLA2 blockade. Yet, it is also important to note that such
potential, compensatory acidifying mechanisms, if operative, did
not normalize pH during these experiments. We then demon-
strated the speci®city of this reaction through the ability of
Figure 3. Coapplication of FFA (stearic acid,
palmitic acid) with sPLA2 inhibitor
normalizes SC integrity and cohesion. (A, B)
Integrity and cohesion data, respectively, after 3 d
of BPB 6 stearic acid application to intact skin.
(C, D) Similar data on integrity and cohesion after
3 d of BPB 6 PA application to intact skin.
Indicated p-values for (A)±(D) were derived by
ANOVA. (A) Posthoc (Bonferroni) test revealed p
< 0.01 for BPB versus both groups for four and
®ve D-Squame strippings, (B) p < 0.01 for BPB
versus both groups for two, three, four, and ®ve
D-Squame strippings, and p < 0.05 for BPB versus
vehicle for one D-Squame stripping. (C)
Bonferroni test: p < 0.01 for BPB versus vehicle at
all data points and p < 0.05 for BPB versus BPB/
PA for three, four, and ®ve D-Squame strippings.
(D) Bonferroni test: p < 0.01 for BPB versus both
groups for all data points.
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coapplications of either FFA or an acidic pH buffer to restore a
normal acidic pH to inhibitor-treated SC. Thus, it can be assumed
that sPLA2-mediated catabolism of PL to FFA represents an
important acidifying mechanism in normal SC.
FA are one of the three major lipid species of the SC, which
together account for about 10% of SC by weight (Yardley and
Summerly, 1981; Schurer and Elias, 1991). Cytochemical studies
have shown that sPLA2 activity (Freinkel and Traczyk, 1985) is
codelivered to the SC interstices, along with PL (Grayson et al,
1985), through the secretion of epidermal lamellar body contents at
the SG±SC interface (Elias et al, 1988). Moreover, there is also
evidence that PL-to-FFA generation is an early catabolic event in a
sequence of biochemical reactions that transforms secreted polar
lipids into their nonpolar products (Long et al, 1985; Elias et al,
1988; Mao-Qiang et al, 1995; 1996). Although there are no other
sources of FFA among the secreted, lamellar-body-derived polar
lipids, in theory FFA could also be generated in the outer SC from
the catabolism of nonlamellar-body-derived triglycerides by the
abundant triacylglycerol lipase that is delivered to the SC interstices
by lamellar body secretion (Grayson et al, 1985; Menon et al,
1986). Moreover, whereas only small quantities of triglycerides are
present in SC (Hedberg et al, 1988; Schurer and Elias, 1991), large
amounts of triglycerides are synthesized in both the nucleated layers
of the epidermis (Monger et al, 1988) and sebaceous glands (Thody
and Shuster, 1989; Stewart and Downing, 1991). Yet, although
Figure 4. Exposure of intact skin to neutral pH buffer produces
similar changes in SC pH, barrier function, and integrity.
Anesthetized mice were immersed for 3 h in HEPES buffer, adjusted to
pH 7.4 or pH 5.5. (A) After exposure to HEPES buffer pH 7.4 the pH
of SC is signi®cantly elevated in comparison to skin surfaces exposed to
HEPES buffer pH 5.5. (B) An abnormality in SC integrity is also
apparent. (C) The changes in SC cohesion after 3 h exposure to HEPES
buffer, pH 7.4 vs pH 5.5, are also signi®cant.
Figure 5. A neutral pH buffer ampli®es the sPLA2-inhibitor-
induced alteration in pH, whereas an acidic buffer overrides
inhibitor-induced alterations in barrier function and integrity.
The hairless mice were ®rst treated with the sPLA2 inhibitor BPB for 3
d and then exposed to HEPES buffer, either pH 7.4 or pH 5.5, for 3 h.
(A) Exposure to HEPES buffer pH 7.4 for 3 h ampli®es the BPB-
induced barrier abnormality, whereas exposure to HEPES buffer pH 5.5
prevents this change. The calculated ANOVA was not signi®cant and
thus a posthoc comparison was not performed. (B) After 3 d of BPB
treatment, a signi®cant barrier abnormality is present (cf. Fig 2). This
abnormality is ampli®ed by 3 h exposure to HEPES buffer at pH 7.4,
but not at pH 5.5. (C) Three days of BPB treatment plus 3 h of
exposure to HEPES buffer at either pH 7.4 or pH 5.5. Both treatments
cause a further decline in SC integrity, but the defect is exacerbated
signi®cantly at pH 7.4 vs pH 5.5.
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some FFA could, in theory, derive from epidermal (nonlamellar
body) and/or sebaceous gland sources, we found no changes in SC
pH either in asebia (Asb-J) mice that lack sebaceous glands nor in
animals treated with the topical lipase inhibitor orlistat (Elias PM,
Mao-Qiang M, Kao J, Feingold KR, unpublished observations).
Thus, a speci®c PL-derived pool of FFA accounts for the observed,
FFA-induced changes in skin surface pH.
Regardless of the origin of FFA, these lipids are segregated
within the interstices of normal SC. Within this compartment, they
could regulate the pH selectively, resulting in modulation of pH-
sensitive functions of the SC (Fig 9). Indeed, we showed here that
certain key functions of the SC are regulated in parallel with the pH
changes induced by a lack of PL-derived FFA. As shown
previously, we showed again that inhibition of sPLA2 results in a
permeability barrier abnormality, and that coapplications of FFA
normalize barrier function (Mao-Qiang et al, 1995, 1996). These
prior studies showed that depletion of PL-derived FFA results in
membrane structural abnormalities attributable to an altered ratio of
the three key SC lipids function (Mao-Qiang et al, 1995, 1996).
The question remains, however, whether an acidic pH alone could
compensate for depletion of FFA in correcting the barrier. In fact,
an alteration in pH alone could theoretically alter barrier home-
ostasis by at least two different mechanisms (Fig 9). First, barrier
recovery after acute perturbations is delayed at a neutral pH,
attributable to altered extracellular processing of secreted lamellar
body polar lipids (Mauro et al, 1998). Moreover, both b-
glucocerebrosidase and acid sphingomyelinase, enzymes that are
required for the generation of ceramides from glucosylceramides
and sphingomyelin, respectively, exhibit acidic pH optima
(Holleran et al, 1992; Jensen et al, 1999; Takagi et al, 1999).
Accordingly, an elevated SC pH could alter barrier function by
blockade of ceramide generation from their two polar lipid
precursors. Second, a neutral pH could directly impair the
structural organization of lamellar membrane structures. Bouwstra
et al (1998, 1999) have shown that the pKa resulting from an acidic
pH allows FFA to assemble more ef®ciently into ceramide and
cholesterol-containing membrane bilayers. Yet, whereas the BPB-
induced barrier abnormality could be prevented by coapplied FFA,
it could not be reversed by an acidic pH buffer alone: barrier
recovery after acute perturbation is delayed comparably when BPB
is applied in either a neutral or an acidic buffer (Fluhr JW, Feingold
KR, Elias PM, unpublished observations). Thus, whereas the pH-
related mechanism clearly is important for barrier homeostasis, it
cannot substitute for PL-derived generation of FFA.
A second functional consequence of FFA-mediated acidi®cation
relates to modulations of SC integrity/cohesion (Fig 9). Elevation
Figure 6. Treatment with two sPLA2 inhibitors reduced
desmosome density in the lower SC. (B, C) Hairless mouse skin
treated with the sPLA2 inhibitor BPB. Note the diminution of intact
desmosomes (solid arrow) at the SG±SC interface with the presence of
desmosomal remnants (open arrows). In contrast, coapplication of PA with
BPB maintains normal desmosome numbers (A, solid arrows and
arrowheads). (D) Vehicle (VEH)-treated SC ± desmosome numbers in the
SC appear to be normal (D, solid arrows). (A)±(D) OsO4 post®xation.
Magni®cation bars, 0.5 mm.
Figure 7. Treatment with the sPLA2 inhibitor BPB reduces
desmosoglein labeling in the lower SC. Reduction in desmosomes
in inhibitor-treated skin is also shown by the decrease in DSG 1
immunolabeling in the lower SC of BPB versus vehicle-treated SC, on
laser confocal microscopy (A). In contrast DSG 1 staining in vehicle-
treated SC remained prominent (B).
Figure 8. Treatment with the sPLA2 inhibitor MJ33 reduces
corneodesmosomes in the lower SC. Reduction of
corneodesmosomes after MJ33 treatment, an effect that could be
prevented by coapplication of the FFA PA. Indicated p-value was
determined by ANOVA; the posthoc (Bonferroni) test revealed p < 0.05
for MJ33 versus MJ33 + PA and MJ33 versus vehicle.
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of pH through inhibition of sPLA2 compromised both SC integrity
and SC cohesion, as evidenced by an sPLA2-inhibitor-induced
decrease in resistance to sequential strippings, and an increase in the
quantity of protein removed per stripping, respectively. Again, the
link between sPLA2 inhibition and diminished SC integrity was
shown by the normalization of SC integrity/cohesion that followed
reacidi®cation with either coapplied FFA or exposure to an acidic
buffer. Conversely, integrity/cohesion deteriorated further when
inhibitor-treated skin was exposed to a neutral pH buffer. We also
showed that the basis for diminished SC cohesion with sPLA2
blockade correlates with a premature dissolution of corneodesmo-
somes. Corneodesmosomes normally persist into the mid SC, but
in sPLA2-inhibitor-treated skin extensive degradation/dissolution
was evident in the mid to lower SC, extending even to the SG±SC
interface. Conversely, coapplication of FFA with the inhibitors
restored normal corneodesmosome densities. Accordingly, desmo-
glein immunolabeling of corneocytes decreased abruptly above the
SG±SC interface in inhibitor-treated skin. The accelerated dis-
solution of desmosomes in sPLA2-inhibitor-treated skin could
re¯ect increased activities of the SC chymotryptic and tryptic
enzymes, which display neutral-to-alkaline pH optima (Brattsand
and Egelrud, 1999; Egelrud, 2000). In contrast, the low
desquamation rates (increased cohesion) that occur in intact skin
could re¯ect a decrease in activity of one or both of these two
enzymes. Further studies will be needed to ascertain the enzymatic
basis for the sPLA2-inhibitor-induced alterations in SC integrity
and cohesion.
In summary, topical applications of two chemically unrelated
sPLA2 inhibitors produced an increase in the skin surface pH of
murine SC that was paralleled by a permeability barrier abnorm-
ality, altered SC integrity, and decreased SC cohesion. Not only SC
pH but also all of the functional abnormalities normalized when
FFA were coapplied with the inhibitors. Short-term applications of
a neutral pH buffer to inhibitor-treated skin further ampli®ed the
abnormalities in SC integrity and cohesion. Finally, the alterations
in integrity/cohesion were linked to premature dissolution of
corneodesmosomes.
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